Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
J Perinatol ; 44(5): 751-759, 2024 May.
Article in English | MEDLINE | ID: mdl-38615125

ABSTRACT

BACKGROUND: Extrauterine growth restriction from inadequate nutrition remains a significant morbidity in very low birth weight infants. Participants in the California Perinatal Quality Care Collaborative Quality Improvement Collaborative, Grow, Babies, Grow! developed or refined tools to improve nutrition and reduce practice variation. METHOD: Five Neonatal Intensive Care Units describe the development and implementation of nutrition tools. Tools include Parenteral Nutrition Guidelines, Automated Feeding Protocol, electronic medical record Order Set, Nutrition Time-Out Rounding Tool, and a Discharge Nutrition Recommendations. 15 of 22 participant sites completed a survey regarding tool value and implementation. RESULTS: Reduced growth failure at discharge was observed in four of five NICUs, 11-32% improvement. Tools assisted with earlier TPN initiation (8 h) and reaching full feeds (2-5 days). TPN support decreased by 5 days. 80% of survey respondents rated the tools as valuable. CONCLUSION: Evidence and consensus-based nutrition tools help promote standardization, leading to improved and sustainable outcomes.


Subject(s)
Intensive Care Units, Neonatal , Quality Improvement , Humans , Infant, Newborn , Intensive Care Units, Neonatal/standards , California , Infant, Very Low Birth Weight , Practice Guidelines as Topic , Parenteral Nutrition/standards , Evidence-Based Medicine , Infant Nutritional Physiological Phenomena , Female
2.
Dev Dyn ; 252(6): 728-741, 2023 06.
Article in English | MEDLINE | ID: mdl-36866634

ABSTRACT

BACKGROUND: Maintenance of the Drosophila male germline stem cells (GSCs) requires activation of the Janus kinase/signal transducer and activators of transcription (JAK/STAT) pathway by niche signals. The precise role of JAK/STAT signaling in GSC maintenance, however, remains incompletely understood. RESULTS: Here, we show that, GSC maintenance requires both canonical and non-canonical JAK/STAT signaling, in which unphosphorylated STAT (uSTAT) maintains heterochromatin stability by binding to heterochromatin protein 1 (HP1). We found that GSC-specific overexpressing STAT, or even the transcriptionally inactive mutant STAT, increases GSC number and partially rescues the GSC-loss mutant phenotype due to reduced JAK activity. Furthermore, we found that both HP1 and STAT are transcriptional targets of the canonical JAK/STAT pathway in GSCs, and that GSCs exhibit higher heterochromatin content. CONCLUSIONS: These results suggest that persistent JAK/STAT activation by niche signals leads to the accumulation of HP1 and uSTAT in GSCs, which promote heterochromatin formation important for maintaining GSC identity. Thus, the maintenance of Drosophila GSCs requires both canonical and non-canonical STAT functions within GSCs for heterochromatin regulation.


Subject(s)
Drosophila Proteins , Janus Kinases , Animals , Janus Kinases/genetics , Janus Kinases/metabolism , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Heterochromatin/genetics , Heterochromatin/metabolism , STAT Transcription Factors/genetics , STAT Transcription Factors/metabolism , Signal Transduction/physiology , Drosophila/genetics , Germ Cells/metabolism , Chromobox Protein Homolog 5 , Stem Cells , Drosophila melanogaster/genetics , Stem Cell Niche/physiology
3.
Biomater Sci ; 9(2): 482-495, 2021 Jan 21.
Article in English | MEDLINE | ID: mdl-32812951

ABSTRACT

Providing physicians with new imaging agents to help detect cancer with better sensitivity and specificity has the potential to significantly improve patient outcomes. Development of new imaging agents could offer improved early cancer detection during routine screening or help surgeons identify tumor margins for surgical resection. In this study, we evaluate the optical properties of a colorful class of dyes and pigments that humans routinely encounter. The pigments are often used in tattoo inks and the dyes are FDA approved for the coloring of foods, drugs, and cosmetics. We characterized their absorption, fluorescence and Raman scattering properties in the hopes of identifying a new panel of dyes that offer exceptional imaging contrast. We found that some of these coloring agents, coined as "optical inks", exhibit a multitude of useful optical properties, outperforming some of the clinically approved imaging dyes on the market. The best performing optical inks (Green 8 and Orange 16) were further incorporated into liposomal nanoparticles to assess their tumor targeting and optical imaging potential. Mouse xenograft models of colorectal, cervical and lymphoma tumors were used to evaluate the newly developed nano-based imaging contrast agents. After intravenous injection, fluorescence imaging revealed significant localization of the new "optical ink" liposomal nanoparticles in all three tumor models as opposed to their neighboring healthy tissues (p < 0.05). If further developed, these coloring agents could play important roles in the clinical setting. A more sensitive imaging contrast agent could enable earlier cancer detection or help guide surgical resection of tumors, both of which have been shown to significantly improve patient survival.


Subject(s)
Neoplasms , Tattooing , Coloring Agents , Contrast Media , Humans , Ink , Optical Imaging
4.
JCO Oncol Pract ; 16(9): e1045-e1049, 2020 09.
Article in English | MEDLINE | ID: mdl-32339470

ABSTRACT

PURPOSE: Oncology care reimbursement has been shifting from a traditional fee-for-service model to either 1- or 2-sided risk models during the past 5 years. A major expense associated with the total cost of care is hospitalization cost. The study set out to investigate whether the creation of an Advanced Community Care Model (ACCM) of home health care would affect 60-day hospitalization and 30-rehospitalization rates in a community oncology setting. METHODS: In conjunction with a single home health care organization, an ACCM was modified for oncology care to include intervention protocols to address antiemetic issues, pain control, dehydration, shortness of breath, diarrhea, and fever. Weekly and monthly joint management meetings began. Quality metrics were defined. RESULTS: Overall, 457 unique home health care admissions were evaluated. Hospitalization associated with intervention protocols was evaluated. Sixty-day hospitalization rates decreased from 14% to 8%. Thirty-day rehospitalization rates decreased from 25% to 10%. CONCLUSION: An oncology ACCM, as created in this study, appears to have reduced both 60-day hospitalization and 30-day rehospitalization rates.


Subject(s)
Home Care Services , Medicine , Fee-for-Service Plans , Hospitalization , Humans
5.
J Clin Psychol Med Settings ; 20(2): 173-85, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23179073

ABSTRACT

Depression and posttraumatic stress (PTS) have been linked to medical/psychological outcomes following coronary artery bypass graft (CABG) surgery. This study assessed pre-surgical trauma history, PTS, and depression; and peri-surgical appraisals of fear, helplessness, and perceived life-threat among 110 patients. All CABGs were emergent, rather than elective, surgeries. In hierarchical multiple regressions, total severity score for pre-surgical PTS predicted fear regarding the cardiac event and the CABG, and perceived life-threat regarding the cardiac event and the CABG. Pre-surgical depression predicted perceived helplessness regarding the cardiac event and the CABG, and contributed to prediction of perceived life-threat. Trauma history contributed to prediction of fear and perceived helplessness regarding surgery (but not regarding the cardiac event necessitating surgery). When posttraumatic stress disorder diagnosis (PTSD) was entered, rather than total severity of PTS, PTSD did not predict any appraisals, and depression showed stronger prediction of fear, helplessness, and perceived life-threat than did PTSD.


Subject(s)
Cardiac Surgical Procedures/psychology , Coronary Disease/epidemiology , Depressive Disorder/epidemiology , Fear , Internal-External Control , Stress Disorders, Post-Traumatic/epidemiology , Aged , Cardiac Surgical Procedures/adverse effects , Coronary Disease/surgery , Emergencies , Female , Humans , Life Change Events , Male , Middle Aged , Prevalence , Regression Analysis , Risk Factors , United States/epidemiology
6.
PLoS Genet ; 8(1): e1002473, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22291607

ABSTRACT

Organismal aging is influenced by a multitude of intrinsic and extrinsic factors, and heterochromatin loss has been proposed to be one of the causes of aging. However, the role of heterochromatin in animal aging has been controversial. Here we show that heterochromatin formation prolongs lifespan and controls ribosomal RNA synthesis in Drosophila. Animals with decreased heterochromatin levels exhibit a dramatic shortening of lifespan, whereas increasing heterochromatin prolongs lifespan. The changes in lifespan are associated with changes in muscle integrity. Furthermore, we show that heterochromatin levels decrease with normal aging and that heterochromatin formation is essential for silencing rRNA transcription. Loss of epigenetic silencing and loss of stability of the rDNA locus have previously been implicated in aging of yeast. Taken together, these results suggest that epigenetic preservation of genome stability, especially at the rDNA locus, and repression of unnecessary rRNA synthesis, might be an evolutionarily conserved mechanism for prolonging lifespan.


Subject(s)
Aging/genetics , Chromosomal Proteins, Non-Histone/genetics , Drosophila melanogaster/genetics , Drosophila melanogaster/physiology , Heterochromatin/genetics , Longevity/genetics , RNA, Ribosomal/biosynthesis , Animals , Cell Nucleolus/genetics , Chromobox Protein Homolog 5 , DNA, Circular/genetics , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Epigenesis, Genetic/genetics , Genomic Instability , Janus Kinases/genetics , Janus Kinases/metabolism , Muscles/physiology , RNA, Ribosomal/genetics , STAT Transcription Factors/genetics , STAT Transcription Factors/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, Genetic/genetics
7.
PLoS Genet ; 7(5): e1002086, 2011 May.
Article in English | MEDLINE | ID: mdl-21637778

ABSTRACT

In many organisms, transcription of the zygotic genome begins during the maternal-to-zygotic transition (MZT), which is characterized by a dramatic increase in global transcriptional activities and coincides with embryonic stem cell differentiation. In Drosophila, it has been shown that maternal morphogen gradients and ubiquitously distributed general transcription factors may cooperate to upregulate zygotic genes that are essential for pattern formation in the early embryo. Here, we show that Drosophila STAT (STAT92E) functions as a general transcription factor that, together with the transcription factor Zelda, induces transcription of a large number of early-transcribed zygotic genes during the MZT. STAT92E is present in the early embryo as a maternal product and is active around the MZT. DNA-binding motifs for STAT and Zelda are highly enriched in promoters of early zygotic genes but not in housekeeping genes. Loss of Stat92E in the early embryo, similarly to loss of zelda, preferentially down-regulates early zygotic genes important for pattern formation. We further show that STAT92E and Zelda synergistically regulate transcription. We conclude that STAT92E, in conjunction with Zelda, plays an important role in transcription of the zygotic genome at the onset of embryonic development.


Subject(s)
Drosophila Proteins/metabolism , Drosophila melanogaster/genetics , STAT Transcription Factors/metabolism , Transcription Factors/metabolism , Zygote/metabolism , Animals , Binding Sites , Body Patterning , Cells, Cultured , Drosophila Proteins/genetics , Drosophila melanogaster/embryology , Drosophila melanogaster/physiology , Embryo, Nonmammalian/metabolism , Gene Expression Regulation, Developmental , Genes, Reporter , Larva/metabolism , Larva/physiology , Nuclear Proteins , Promoter Regions, Genetic , STAT Transcription Factors/genetics , Signal Transduction , Transcription Factors/genetics , Transcriptional Activation , Zygote/growth & development
8.
J Am Chem Soc ; 131(37): 13244-5, 2009 Sep 23.
Article in English | MEDLINE | ID: mdl-19754185

ABSTRACT

Total synthesis of the Galbulimima alkaloid G. B. 13 was achieved utilizing a functionalized pyridine moiety as a piperidine surrogate. Key to the success of the synthesis was the development of an unprecedented rhodium-catalyzed 1,2-addition of an arylboronic ester into an unactivated ketone.


Subject(s)
Alkaloids/chemistry , Alkaloids/chemical synthesis , Ketones/chemistry , Pyridines/chemistry , Rhodium/chemistry , Boron/chemistry , Catalysis , Esters/chemistry , Models, Molecular , Molecular Conformation , Oxidation-Reduction , Piperidines/chemistry
9.
PLoS Biol ; 6(5): e128, 2008 May 20.
Article in English | MEDLINE | ID: mdl-18494562

ABSTRACT

The proto-oncoprotein Raf is pivotal for mitogen-activated protein kinase (MAPK) signaling, and its aberrant activation has been implicated in multiple human cancers. However, the precise molecular mechanism of Raf activation, especially for B-Raf, remains unresolved. By genetic and biochemical studies, we demonstrate that phosphorylation of tyrosine 510 is essential for activation of Drosophila Raf (Draf), which is an ortholog of mammalian B-Raf. Y510 of Draf is phosphorylated by the c-src homolog Src64B. Acidic substitution of Y510 promotes and phenylalanine substitution impairs Draf activation without affecting its enzymatic activity, suggesting that Y510 plays a purely regulatory role. We further show that Y510 regulates Draf activation by affecting the autoinhibitory interaction between the N- and C-terminal fragments of the protein. Finally, we show that Src64B is required for Draf activation in several developmental processes. Together, these results suggest a novel mechanism of Raf activation via Src-mediated tyrosine phosphorylation. Since Y510 is a conserved residue in the kinase domain of all Raf proteins, this mechanism is likely evolutionarily conserved.


Subject(s)
Drosophila melanogaster/metabolism , Gene Expression Regulation, Developmental , Phosphotyrosine/metabolism , raf Kinases/metabolism , Animals , Cell Line , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster/enzymology , Enzyme Activation , Glutamic Acid/metabolism , Phosphorylation , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Signal Transduction , raf Kinases/genetics , ras Proteins/metabolism
10.
Nat Cell Biol ; 10(4): 489-96, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18344984

ABSTRACT

STAT (Signal transducer and activator of transcription) is a potent transcription factor and its aberrant activation by phosphorylation is associated with human cancers. We have shown previously that overactivation of JAK, which phosphorylates STAT, disrupts heterochromatin formation globally in Drosophila melanogaster. However, it remains unclear how this effect is mediated and whether STAT is involved. Here, we demonstrate that Drosophila STAT (STAT92E) is involved in controlling heterochromatin protein 1 (HP1) distribution and heterochromatin stability. We found, unexpectedly, that loss of STAT92E, had the same effects as overactivation of JAK in disrupting heterochromatin formation and heterochromatic gene silencing, whereas overexpression of STAT92E had the opposite effects. We have further shown that the unphosphorylated or 'transcriptionally inactive' form of STAT92E is localized on heterochromatin in association with HP1, and is required for stabilizing HP1 localization and histone H3 Lys 9 methylation (H3mK9) . However, activation by phosphorylation reduces heterochromatin-associated STAT92E, causing HP1 displacement and heterochromatin destabilization. Thus, reducing levels of unphosphorylated STAT92E, either by loss of STAT92E or increased phosphorylation, causes heterochromatin instability. These results suggest that activation of STAT by phosphorylation controls both access to chromatin and activity of the transcription machinery.


Subject(s)
Chromosomal Instability , Chromosomal Proteins, Non-Histone/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/genetics , Heterochromatin/metabolism , STAT Transcription Factors/metabolism , Animals , Chromobox Protein Homolog 5 , Chromosomal Proteins, Non-Histone/genetics , Cycloheximide/metabolism , Drosophila Proteins/genetics , Drosophila melanogaster/anatomy & histology , Drosophila melanogaster/embryology , Drosophila melanogaster/metabolism , Embryo, Nonmammalian/anatomy & histology , Embryo, Nonmammalian/metabolism , Gene Silencing , Humans , Janus Kinase 1/genetics , Janus Kinase 1/metabolism , Lysine/metabolism , Protein Synthesis Inhibitors/metabolism , RNA Interference , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , STAT Transcription Factors/genetics
11.
Health Promot Pract ; 8(1): 60-8, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16840767

ABSTRACT

Periconceptional intake of folic acid is known to reduce the risk for neural tube defects (NTDs). To inform southeast Michigan Latina women of childbearing age about the benefits of food and supplemental sources of the micronutrient in the prevention of NTDs, Spanish-English bilingual health educators carried out 20 education events in supermarkets and community organizations serving Latina women. One hundred and sixty Latina women ages 19 to 50 years indicated their current folic acid awareness and stated their future intentions regarding folic acid. Of 160 women surveyed, 114 (71%) had heard of folic acid, 84 (74%) knew that folic acid prevents birth defects, 63 (55%) knew the critical time to take folic acid, and 76 (67%) identified at least one source of folic acid. After participating in the education events, 136 women (85%) reported planning to eat more folate and/or folic acid-rich foods. Although general folic acid awareness is fairly high, health promotion efforts must be coordinated at community locations serving Latina women to share folic acid's specific protective effects in the prevention of NTDs, the critical timing of intake, and its food and supplement sources.


Subject(s)
Awareness , Folic Acid/therapeutic use , Health Promotion/methods , Hispanic or Latino/psychology , Mothers/psychology , Neural Tube Defects/prevention & control , Preconception Care/methods , Adult , Chi-Square Distribution , Female , Humans , Michigan , Middle Aged , Pregnancy
12.
J Chem Inf Model ; 46(4): 1827-35, 2006.
Article in English | MEDLINE | ID: mdl-16859314

ABSTRACT

A series of 13 anthrapyrazole compounds that are analogues of piroxantrone and losoxantrone were synthesized, and their cell growth inhibitory effects, DNA binding, topoisomerase IIalpha mediated (EC 5.99.1.3) cleavage of DNA, and inhibition of DNA topoisomerase IIalpha decatenation catalytic activities were determined. Cell growth inhibitory activity was well-correlated with DNA binding, suggesting that these compounds may act by targeting DNA. However, cell growth inhibition was not well-correlated with the inhibition of topoisomerase IIalpha catalytic activity, suggesting that these anthrapyrazoles did not act solely by inhibiting the catalytic activity of topoisomerase II. Most of the analogues were able to induce DNA cleavage, and thus, it was concluded that they acted, at least in part, as topoisomerase II poisons. Structure-based three-dimensional quantitative structure-activity analyses (3D-QSAR) were carried out on the aligned structures of the anthrapyrazoles docked into DNA using comparative molecular field analysis (CoMFA) and comparative molecular similarity index (CoMSIA) analyses in order to determine the structural features responsible for their activity. Both CoMFA and CoMSIA yielded statistically significant models upon partial least-squares analyses. The 3D-QSAR analyses showed that hydrogen-bond donor interactions and electrostatic interactions with the protonated amino side chains of the anthrapyrazoles led to high cell growth inhibitory activity.


Subject(s)
Anthraquinones/chemistry , Anthraquinones/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Pyrazoles/chemistry , Pyrazoles/pharmacology , Pyrazolones/chemistry , Pyrazolones/pharmacology , Anthracyclines/chemistry , Antigens, Neoplasm/drug effects , DNA/chemistry , DNA/drug effects , DNA Topoisomerases, Type II/drug effects , DNA-Binding Proteins/drug effects , Models, Molecular , Nucleic Acid Conformation , Nucleic Acid Denaturation , Quantitative Structure-Activity Relationship
13.
Oncol Rep ; 15(6): 1575-80, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16685398

ABSTRACT

Anthrapyrazoles have been investigated as cancer chemotherapeutic agents. The mechanism of action of these compounds is thought to involve inhibition of DNA topoisomerase II. A structure-activity study was carried out to determine the in vitro cytotoxic activity of nine novel anthrapyrazoles against human breast carcinoma, head and neck squamous cell carcinoma and leukemia cells, and against Chinese hamster ovary cells. The activity of these anthrapyrazole analogues was compared with that of two clinically tested anthrapyrazoles, losoxantrone and piroxantrone. Inhibition of topoisomerase II as a mechanism of action for the analogues was also investigated. The cytotoxic activity of the analogues was determined in vitro by MTT cell growth inhibition assay and inhibition of catalytic topoisomerase II activity by each compound was measured using a fluorometric DNA decatenation assay. All of the anthrapyrazole analogues inhibited the growth of the four cell lines with IC50 values that ranged from 0.1 to 45.2 microM. Losoxantrone was the most potent of the anthrapyrazole analogues studied. A tertiary amine in the basic side chain at N-2 increased the cytotoxic activity compared with a secondary amine in this side chain for many of the analogues, but not if there was a basic side chain at the C-5 position. A chlorine substituent on the basic side chain at N-2 did not have a consistent effect on activity. Moving the position of a chlorine substituent from C-5 to C-7 or introducing a basic side chain at C-5 did not have a consistent effect on cytotoxic activity. Anthrapyrazole analogues showed a broad range of activity for inhibiting topoisomerase II decatenation activity. Losoxantrone and piroxantrone were the most potent inhibitors of topoisomerase II activity. There was no significant correlation between the cytotoxic activity of the anthrapyrazole analogues and their ability to inhibit decatenation by topoisomerase II.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Topoisomerase II Inhibitors , Animals , Anthracyclines/chemistry , Anthracyclines/pharmacology , CHO Cells , Cricetinae , Cricetulus , DNA Topoisomerases, Type II/genetics , Drug Screening Assays, Antitumor , Humans , Inhibitory Concentration 50 , K562 Cells , Quantitative Structure-Activity Relationship
14.
Org Lett ; 7(26): 5845-8, 2005 Dec 22.
Article in English | MEDLINE | ID: mdl-16354081

ABSTRACT

[reaction: see text] A general set of conditions that achieves the union of aryl halides and divinyl or enyne carbinols to afford tri- or tetrasubstituted olefins in good yields (up to 83%) is described. The mechanism by which this proceeds is believed to involve the intermediacy of a cyclopropanol, followed by a novel skeletal reorganization. The ability to suppress beta-hydride elimination of organopalladium intermediates appears to be critical to the success of these processes.

15.
Med Sci Sports Exerc ; 37(11): 1983-9, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16286870

ABSTRACT

PURPOSE: The magnitude of atrophy and strength loss induced by partial or complete disuse of skeletal muscles varies greatly among individuals. Factors predisposing some individuals to more extreme responses have not been identified. The purpose of this investigation was to determine whether 1) level of activity before disuse or 2) sex differences influence the magnitude of atrophy and changes in muscle strength, endurance, and sense of muscular effort in response to 21 d of arm suspension. METHODS: Thirty-one individuals (18 women, 13 men) completed either 8 wk of resistance training (TRAINED group) or no training (UNTRAINED group) before 21 d of elbow muscle arm suspension achieved by having one arm in a sling tethered to the body by a swathe. Muscle volume was measured using serial magnetic resonance imaging (MRI) cross-sectional images. Functional measurements included maximal isometric force (MIF) for elbow flexion, one-repetition maximum (1RM) for biceps curl, number of repetitions to fatigue at 50% of 1RM, and sense of muscular effort measured using a force-matching task. RESULTS: Flexor muscle volume decreased (P < 0.001) by -7.7 +/- 7.3% across all subjects. The decrease (P < 0.001) in flexor muscle volume was significant in men but not women. Arm suspension induced decreases (P < 0.001) in MIF and 1RM that did not differ across sex or training groups. The number of repetitions to fatigue decreased (P < 0.05) in the UNTRAINED but not TRAINED groups. No changes in sense of muscular effort were measured. CONCLUSION: The smaller initial muscle size or sex-specific factors attenuated muscle loss but not strength or endurance losses in females during disuse. Resistance training before disuse may attenuate the loss in muscular endurance.


Subject(s)
Immobilization , Muscle, Skeletal/pathology , Muscle, Skeletal/physiology , Weight Lifting , Adult , Arm/physiology , Atrophy/physiopathology , Exercise Therapy , Female , Humans , Male , Muscle Weakness/physiopathology , Physical Endurance , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...